Painful Diabetic Neuropathies Withdrawn Phase 2 Trials for Pregabalin (DB00230)

Also known as: Painful Diabetic Neuropathy / Diabetic Neuropathies, Painful / Painful Diabetic Neuropathy (PDN) / Diabetic Neuropathy, Painful; Diabetic Neuropathies / Diabetic Neuropathy, Painful

IndicationStatusPhase
DBCOND0055434 (Painful Diabetic Neuropathies)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00837941A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)Treatment